Wednesday, October 1, 2014

Drugmaker Lannett Puts Negative Headlines Behind It



Investor's Business Daily - Investing RSS http://ift.tt/YPaW7a Buyers have come back into Lannett Co. (LCI) in recent weeks as the company tries to put some negative headlines behind it. Lannett makes generic drugs for a wide range of medical indications. With a market capitalization of $1.6 billion, the company has benefited from increasing mutual fund sponsorship in recent quarters. Fund ownership has tripled over the past two years, from 91 funds to 276 funds. Its average daily volume has improved from


No comments:

Post a Comment